G.I. View is a developer of a new generation colonoscope, the Aer-O-Scope™, which aims to provide enhanced patient comfort, together with more extensive imaging of the colon wall. The device is in its development stage. In the second quarter of 2022, the Fund closed the sale of its holdings in G.I. View to other internal investors.